C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 5/08 (2006.01) A61K 35/14 (2006.01) A61K 35/28 (2006.01) A61K 48/00 (2006.01) C12N 5/06 (2006.01) A61K 35/12 (2006.01)
Patent
CA 2109729
2109729 9318648 PCTABS00025 A composition comprising human neutrophil precursor cells, wherein the cellular component is comprised of at least about 16 % human myeloblasts and promyelocytes, which have been derived from neutrophil progenitor cells obtained from peripheral blood, bone marrow or cord blood, and less than about 5 % colony forming units (CFU) of at least about 50 cells is provided. An alternative composition comprising human neutrophil precursor cells, wherein the cellular component is comprised of at least about 16 % CD15+CD11b- cells and less than about 5 % colony forming units (CFU) of at least about 50 cells also is provided, wherein at least about 60 % of the CD15+CD11b- cells are myeloblasts and promyelocytes.
Bender James G.
Maples Phillip B.
Smith Stephen
Unverzagt Kristen L.
Van Epps Dennis E.
Nexell Therapeutics Inc.
Sim & Mcburney
LandOfFree
In vitro-derived human neutrophil precursor cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with In vitro-derived human neutrophil precursor cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and In vitro-derived human neutrophil precursor cells will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1892622